Investment
Features
FeesSafety
Academy
More
Pluang+

Kodiak Copper expands mineralized zone at Ketchan deposit with strong 2026 drill results

Company Fundamentals
14 Oct 2026
Newsfile Corp
View Source
Bullish
Kodiak Copper expands mineralized zone at Ketchan deposit with strong 2026 drill results

Kodiak Copper Corp. reported new drill results from its 2026 summer program at the Ketchan deposit in British Columbia, expanding the mineralized zone by at least 450 meters beyond the known 1.4 km strike length. Key drill holes showed significant copper, gold, and silver mineralization, confirming a large geophysical anomaly and suggesting potential for further resource growth. The company plans to continue drilling through late 2026 and aims to update its Mineral Resource Estimate in early 2027. These results highlight the project's potential to become a major copper-gold porphyry deposit in a well-established mining region.

Kodiak Copper's expansion of mineralization at Ketchan is notable alongside Basic Materials sector activity on Pluang. For readers following Basic Materials, here is Pluang's market snapshot as of Oct 14, 2026 17:11 WIB: out of 83 priced US stocks, 42 rose and 34 fell. AngloGold Ashanti Limited (AU) traded at USD 92.61 with a 1-day change of +1.05% and a typical hold time of 49 days, showing 97% buy order activity. Icl Group Ltd (ICL) was priced at USD 5.03, up 1.00%, with 100% buy order activity and a 56-day hold time. Hycroft Mining Holding Corporation Class A (HYMC) closed at USD 17.74, up 0.97%.

More News

CodeWall raises $4M to launch AI-driven autonomous attack agents for continuous enterprise security testing.

CodeWall raises $4M to launch AI-driven autonomous attack agents for continuous enterprise security testing.

CodeWall Ltd. has emerged from stealth with $4 million in pre-seed funding to develop AI-powered autonomous attack agents that simulate real-world cyberattacks on enterprises. These agents start from outside the network with no insider access, contin...

Others
Bullish
1 hour ago
Matchpoint Therapeutics names John O’Malley as Chief Medical Officer to advance autoimmune drug pipeline.

Matchpoint Therapeutics names John O’Malley as Chief Medical Officer to advance autoimmune drug pipeline.

Matchpoint Therapeutics has appointed John O’Malley, M.D., Ph.D., as its Chief Medical Officer. Dr. O’Malley brings extensive experience in immunology and clinical development from his previous roles at CRISPR Therapeutics and Sanofi. His leadership ...

Market News
Bullish
2 hours ago
FDA accepts Orvida Pharma's KM-023 into Rare Disease Evidence Principles process for Olmsted syndrome

FDA accepts Orvida Pharma's KM-023 into Rare Disease Evidence Principles process for Olmsted syndrome

Orvida Pharma announced that the FDA has accepted its lead drug candidate KM-023 (ontivatrep) into the Rare Disease Evidence Principles (RDEP) process for treating Olmsted syndrome, a rare genetic skin disorder. This acceptance allows Orvida to engag...

Market News
Bullish
2 hours ago
DMC Global to release Q3 2026 financial results on October 27 after market close

DMC Global to release Q3 2026 financial results on October 27 after market close

DMC Global Inc. will announce its financial results for the third quarter ending September 30, 2026, on October 27 after the stock market closes. The company will hold a conference call and webcast to discuss the results, providing investors with ins...

Company Fundamentals
Neutral
2 hours ago
Radware launches MCP Server Protection to secure AI integration layers from attacks and abuse.

Radware launches MCP Server Protection to secure AI integration layers from attacks and abuse.

Radware introduced its Model Context Protocol (MCP) Server Protection solution to help organizations secure the integration layer where AI agents connect to enterprise applications and workflows. This new security tool provides visibility into MCP in...

Market News
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App